Study of baicalin in inducing prostate cancer cell line DU145 apoptosis in vitro.
- Author:
Zheng-Qin GU
;
Ying-Hao SUN
;
Chuan-Liang XU
;
Yi LIU
- Publication Type:Journal Article
- MeSH: Antineoplastic Agents, Phytogenic; pharmacology; Apoptosis; drug effects; Cell Line, Tumor; Cell Proliferation; drug effects; Dose-Response Relationship, Drug; Flavonoids; isolation & purification; pharmacology; G1 Phase; Humans; Male; Plants, Medicinal; chemistry; Prostatic Neoplasms; metabolism; pathology; Proto-Oncogene Proteins c-bcl-2; metabolism; Scutellaria; chemistry; bcl-2-Associated X Protein; fas Receptor; metabolism
- From: China Journal of Chinese Materia Medica 2005;30(1):63-66
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVEThe purpose of the present study was to investigate the in vitro effects of baicalin on induction of apoptosis in human prostate cancer cell line DU145.
METHODHuman prostate cancer cell line DU145 was treated with different concentration of baicalin in vitro. The apoptosis rate was determined by FACS analysis, cell cycle distribution was detected by flow cytometry, morphological changes and protein analysis were determined by means of electron microscope techniqueand immunohistochemical techniquerespectively.
RESULT50micromol x L(-1) and 125 micromol x L(-1) of baicalin dose-dependently induced apoptosis and inhibited the proliferation of prostate cancer cell DU145 in a dose and time-dependent manner. DNA flow cytometric analysis indicated that baicalin induced a arrest in G1 phase, showing a typical apoptosis peak. Electron microscopy detected a characteristic appearance of the apoptotic cells morphology. Immunohistochemical analysis revealed that induction of apoptosis by ways of inhibition of the bcl-2, loss of the Bax, and upregulation of Fas.
CONCLUSIONThe results indicate that baicalin may induce apoptosis and inhibit proliferation of prostate cancer cells, and has direct anti-tumor effects on human prostate cancer cells.